Breaking News Instant updates and real-time market news.

CDAY

Ceridian

$51.46 /

-0.41 (-0.79%)

07:59
04/24/20
04/24
07:59
04/24/20
07:59

Ceridian price target lowered to $62 from $85 at Cowen

Cowen analyst Bryan Bergin lowered the firm's price target on Ceridian to $62 from $85 and keeps an Outperform rating on the shares. The analyst said the near-term prospects of HCM are broadly on hold until unemployment data improves clearly which is something difficult to expect in the second half of the year.

  • 28

    Apr

  • 06

    May

CDAY Ceridian
$51.46 /

-0.41 (-0.79%)

04/23/20 JPMorgan
Ceridian downgraded to Underweight with $45 target at JPMorgan
04/23/20 Credit Suisse
Ceridian downgraded to Underperform from Neutral at Credit Suisse
04/23/20 JPMorgan
Ceridian downgraded to Underweight from Neutral at JPMorgan
04/16/20 Jefferies
Ceridian downgraded to Hold from Buy at Jefferies

TODAY'S FREE FLY STORIES

Hot Stocks
Amicus receives EMA PRIME designation for CLN6 gene therapy » 07:06
09/24/20
09/24
07:06
09/24/20
07:06
FOLD

Amicus

$13.31 /

-0.485 (-3.52%)

Amicus Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FOLD Amicus
$13.31 /

-0.485 (-3.52%)

FOLD Amicus
$13.31 /

-0.485 (-3.52%)

08/11/20 Citi
Amicus price target raised to $20 from $15 at Citi
06/16/20 BTIG
Amicus initiated with a Buy at BTIG
06/16/20 H.C. Wainwright
Amicus has positive read from Sanofi COMET data, says H.C. Wainwright
06/09/20 Citi
Amicus shares worth $10 on Galafold alone, says Citi
FOLD Amicus
$13.31 /

-0.485 (-3.52%)

Hot Stocks
Neptune Wellness signs supply agreement with British Columbia cannabis retailer » 07:05
09/24/20
09/24
07:05
09/24/20
07:05
NEPT

Neptune Wellness

$2.16 /

-0.205 (-8.67%)

Neptune Wellness has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NEPT Neptune Wellness
$2.16 /

-0.205 (-8.67%)

NEPT Neptune Wellness
$2.16 /

-0.205 (-8.67%)

08/27/20 Alliance Global Partners
Neptune Wellness deal shows ability to succeed in traditonal category, says AGP
08/07/20
Fly Intel: Top analyst initiations
08/07/20 Alliance Global Partners
Neptune Wellness initiated with a Buy at Alliance Global Partners
01/31/20 Cowen
Neptune Wellness initiated with a Market Perform at Cowen
NEPT Neptune Wellness
$2.16 /

-0.205 (-8.67%)

NEPT Neptune Wellness
$2.16 /

-0.205 (-8.67%)

Hot Stocks
Leap Therapeutics granted FDA Fast Track Designation for DKN-01 » 07:05
09/24/20
09/24
07:05
09/24/20
07:05
LPTX

Leap Therapeutics

$1.80 /

-0.095 (-5.01%)

Leap Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LPTX Leap Therapeutics
$1.80 /

-0.095 (-5.01%)

LPTX Leap Therapeutics
$1.80 /

-0.095 (-5.01%)

06/29/20 Piper Sandler
Leap Therapeutics initiated with an Overweight at Piper Sandler
02/10/20 Baird
Leap Therapeutics initiated with an Outperform at Baird
01/08/20 Raymond James
Raymond James upgrades Leap Therapeutics to Outperform on BeiGene deal
01/08/20 Raymond James
Leap Therapeutics upgraded to Outperform from Market Perform at Raymond James
LPTX Leap Therapeutics
$1.80 /

-0.095 (-5.01%)

  • 18
    Jun
LPTX Leap Therapeutics
$1.80 /

-0.095 (-5.01%)

Upgrade
Antofagasta upgraded to Equal Weight amid return of inflation at Morgan Stanley » 07:05
09/24/20
09/24
07:05
09/24/20
07:05
ANFGF

Antofagasta

/

+

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANFGF Antofagasta
/

+

09/23/20 Morgan Stanley
Antofagasta upgraded to Equal Weight from Underweight at Morgan Stanley
09/15/20 Barclays
Antofagasta price target raised to 875 GBp from 725 GBp at Barclays
08/27/20 Investec
Antofagasta downgraded to Hold from Buy at Investec
08/25/20 BMO Capital
Antofagasta price target raised to GBp 1,000 at BMO
Recommendations
William Blair uncovers second large, unannounced contract win for SAIC » 07:05
09/24/20
09/24
07:05
09/24/20
07:05
SAIC

SAIC

$75.60 /

-2.75 (-3.51%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAIC SAIC
$75.60 /

-2.75 (-3.51%)

SAIC SAIC
$75.60 /

-2.75 (-3.51%)

09/16/20 William Blair
SAIC seems to have won 8th largest contract at $753M, says William Blair
09/08/20 JPMorgan
SAIC removed from Analyst Focus List at JPMorgan
09/03/20 Citi
SAIC price target raised to $105 from $100 at Citi
06/12/20 William Blair
William Blair sees near-term takeover of Perspecta as unlikely despite Jana news
SAIC SAIC
$75.60 /

-2.75 (-3.51%)

  • 16
    Jan
SAIC SAIC
$75.60 /

-2.75 (-3.51%)

Earnings
Rite Aid reports Q2 adj. EPS 25c, consensus 0c » 07:05
09/24/20
09/24
07:05
09/24/20
07:05
RAD

Rite Aid

$13.36 /

-0.165 (-1.22%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RAD Rite Aid
$13.36 /

-0.165 (-1.22%)

RAD Rite Aid
$13.36 /

-0.165 (-1.22%)

09/01/20 Deutsche Bank
Walgreens CEO hire 'bit of a step backward,' says Deutsche Bank
06/26/20 JPMorgan
Rite Aid price target raised to $17 from $12 at JPMorgan
06/26/20 Deutsche Bank
Rite Aid price target raised to $18 from $12 at Deutsche Bank
04/17/20
Fly Intel: Top five analyst upgrades
RAD Rite Aid
$13.36 /

-0.165 (-1.22%)

RAD Rite Aid
$13.36 /

-0.165 (-1.22%)

RAD Rite Aid
$13.36 /

-0.165 (-1.22%)

RAD Rite Aid
$13.36 /

-0.165 (-1.22%)

Earnings
FactSet sees 2021 adjusted EPS $10.75-$$11.15, consensus $10.84 » 07:04
09/24/20
09/24
07:04
09/24/20
07:04
FDS

FactSet

$331.47 /

-7.465 (-2.20%)

Sees 2021 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FDS FactSet
$331.47 /

-7.465 (-2.20%)

FDS FactSet
$331.47 /

-7.465 (-2.20%)

06/26/20 DA Davidson
FactSet price target raised to $288 from $260 at DA Davidson
06/11/20 Northcoast
FactSet downgraded to Sell ahead of earnings at Northcoast
06/11/20 Northcoast
FactSet downgraded to Sell from Neutral at Northcoast
06/09/20 DA Davidson
FactSet price target raised to $260 from $225 at DA Davidson
FDS FactSet
$331.47 /

-7.465 (-2.20%)

FDS FactSet
$331.47 /

-7.465 (-2.20%)

Hot Stocks
Darden backs FY21 CapEx view $250M-$300M, 35-40 net new restaurants  07:03
09/24/20
09/24
07:03
09/24/20
07:03
DRI

Darden

$89.94 /

-0.02 (-0.02%)

 
ShowHide Related Items >><<
DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

09/22/20 Oppenheimer
Darden price target raised to $100 from $90 at Oppenheimer
09/21/20
Fly Intel: Top five analyst downgrades
09/21/20 Stephens
Stephens says Darden still a top pick, expects in-line Q1 comps
09/21/20 RBC Capital
Darden price target raised to $97 from $86 at RBC Capital
DRI Darden
$89.94 /

-0.02 (-0.02%)

  • 21
    Apr
DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

Hot Stocks
Wells Fargo and Envestnet Yodlee sign data exchange agreement » 07:03
09/24/20
09/24
07:03
09/24/20
07:03
WFC

Wells Fargo

$22.84 /

-0.82 (-3.47%)

Wells Fargo & Company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WFC Wells Fargo
$22.84 /

-0.82 (-3.47%)

WFC Wells Fargo
$22.84 /

-0.82 (-3.47%)

06:11 Today Baird
Wells Fargo named 'Bullish Fresh Pick' at Baird
09/14/20 Wolfe Research
Wolfe Research upgrades Wells Fargo on 'very compelling' risk/reward
09/14/20 Wolfe Research
Wells Fargo upgraded to Outperform from Peer Perform at Wolfe Research
09/11/20 UBS
Wells Fargo upgraded to Neutral from Sell at UBS
WFC Wells Fargo
$22.84 /

-0.82 (-3.47%)

WFC Wells Fargo
$22.84 /

-0.82 (-3.47%)

WFC Wells Fargo
$22.84 /

-0.82 (-3.47%)

WFC Wells Fargo
$22.84 /

-0.82 (-3.47%)

Earnings
FactSet reports Q4 adjusted EPS $2.88, consensus $2.54 » 07:03
09/24/20
09/24
07:03
09/24/20
07:03
FDS

FactSet

$331.47 /

-7.465 (-2.20%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FDS FactSet
$331.47 /

-7.465 (-2.20%)

FDS FactSet
$331.47 /

-7.465 (-2.20%)

06/26/20 DA Davidson
FactSet price target raised to $288 from $260 at DA Davidson
06/11/20 Northcoast
FactSet downgraded to Sell ahead of earnings at Northcoast
06/11/20 Northcoast
FactSet downgraded to Sell from Neutral at Northcoast
06/09/20 DA Davidson
FactSet price target raised to $260 from $225 at DA Davidson
FDS FactSet
$331.47 /

-7.465 (-2.20%)

FDS FactSet
$331.47 /

-7.465 (-2.20%)

Earnings
Rite Aid reports Q4 adj. EPS 25c, consensus 0c » 07:03
09/24/20
09/24
07:03
09/24/20
07:03
RAD

Rite Aid

$13.36 /

-0.165 (-1.22%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RAD Rite Aid
$13.36 /

-0.165 (-1.22%)

RAD Rite Aid
$13.36 /

-0.165 (-1.22%)

09/01/20 Deutsche Bank
Walgreens CEO hire 'bit of a step backward,' says Deutsche Bank
06/26/20 JPMorgan
Rite Aid price target raised to $17 from $12 at JPMorgan
06/26/20 Deutsche Bank
Rite Aid price target raised to $18 from $12 at Deutsche Bank
04/17/20
Fly Intel: Top five analyst upgrades
RAD Rite Aid
$13.36 /

-0.165 (-1.22%)

RAD Rite Aid
$13.36 /

-0.165 (-1.22%)

RAD Rite Aid
$13.36 /

-0.165 (-1.22%)

RAD Rite Aid
$13.36 /

-0.165 (-1.22%)

Earnings
Darden sees Q2 diluted cont ops EPS 65c-75c, consensus 35c » 07:03
09/24/20
09/24
07:03
09/24/20
07:03
DRI

Darden

$89.94 /

-0.02 (-0.02%)

Sees Q2 total sales of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

09/22/20 Oppenheimer
Darden price target raised to $100 from $90 at Oppenheimer
09/21/20
Fly Intel: Top five analyst downgrades
09/21/20 Stephens
Stephens says Darden still a top pick, expects in-line Q1 comps
09/21/20 RBC Capital
Darden price target raised to $97 from $86 at RBC Capital
DRI Darden
$89.94 /

-0.02 (-0.02%)

  • 21
    Apr
DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

Earnings
BlackBerry reports Q2 non-GAAP EPS 11c, consensus 2c » 07:02
09/24/20
09/24
07:02
09/24/20
07:02
BB

BlackBerry

$4.80 /

-0.14 (-2.83%)

Reports Q2 non-GAAP…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BB BlackBerry
$4.80 /

-0.14 (-2.83%)

BB BlackBerry
$4.80 /

-0.14 (-2.83%)

06/25/20 Scotiabank
BlackBerry price target raised to $5 from $4.50 at Scotiabank
06/25/20 Canaccord
BlackBerry improvement anticipated throughout year, says Canaccord
04/01/20 MKM Partners
BlackBerry price target lowered to $4.50 from $7.00 at MKM Partners
04/01/20 TD Securities
BlackBerry downgraded to Hold from Buy at TD Securities
BB BlackBerry
$4.80 /

-0.14 (-2.83%)

BB BlackBerry
$4.80 /

-0.14 (-2.83%)

BB BlackBerry
$4.80 /

-0.14 (-2.83%)

BB BlackBerry
$4.80 /

-0.14 (-2.83%)

Syndicate
Taysha Gene Therapies 7.87M share IPO priced at $20.00 » 07:02
09/24/20
09/24
07:02
09/24/20
07:02
TSHA

Taysha Gene Therapies

$0.00 /

+ (+0.00%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 24
    Sep
TSHA Taysha Gene Therapies
$0.00 /

+ (+0.00%)

Hot Stocks
Darden reinstates quarterly dividend of 30c per share » 07:02
09/24/20
09/24
07:02
09/24/20
07:02
DRI

Darden

$89.94 /

-0.02 (-0.02%)

The dividend is payable…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

09/22/20 Oppenheimer
Darden price target raised to $100 from $90 at Oppenheimer
09/21/20
Fly Intel: Top five analyst downgrades
09/21/20 Stephens
Stephens says Darden still a top pick, expects in-line Q1 comps
09/21/20 RBC Capital
Darden price target raised to $97 from $86 at RBC Capital
DRI Darden
$89.94 /

-0.02 (-0.02%)

  • 21
    Apr
DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

Hot Stocks
Darden reports Q1 blended same-restaurant sales down 29%  07:01
09/24/20
09/24
07:01
09/24/20
07:01
DRI

Darden

$89.94 /

-0.02 (-0.02%)

 
ShowHide Related Items >><<
DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

09/22/20 Oppenheimer
Darden price target raised to $100 from $90 at Oppenheimer
09/21/20
Fly Intel: Top five analyst downgrades
09/21/20 Stephens
Stephens says Darden still a top pick, expects in-line Q1 comps
09/21/20 RBC Capital
Darden price target raised to $97 from $86 at RBC Capital
DRI Darden
$89.94 /

-0.02 (-0.02%)

  • 21
    Apr
DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

Earnings
Darden reports Q1 adjusted cont ops EPS 56c, consensus 5c » 07:00
09/24/20
09/24
07:00
09/24/20
07:00
DRI

Darden

$89.94 /

-0.02 (-0.02%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

09/22/20 Oppenheimer
Darden price target raised to $100 from $90 at Oppenheimer
09/21/20
Fly Intel: Top five analyst downgrades
09/21/20 Stephens
Stephens says Darden still a top pick, expects in-line Q1 comps
09/21/20 RBC Capital
Darden price target raised to $97 from $86 at RBC Capital
DRI Darden
$89.94 /

-0.02 (-0.02%)

  • 21
    Apr
DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

DRI Darden
$89.94 /

-0.02 (-0.02%)

Recommendations
Durect study designed to support full approval, says H.C. Wainwright » 06:59
09/24/20
09/24
06:59
09/24/20
06:59
DRRX

Durect

$1.69 /

-0.07 (-3.98%)

, GILD

Gilead

$63.10 /

-0.29 (-0.46%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DRRX Durect
$1.69 /

-0.07 (-3.98%)

GILD Gilead
$63.10 /

-0.29 (-0.46%)

DRRX Durect
$1.69 /

-0.07 (-3.98%)

07/30/20 Oppenheimer
Durect initiated with an Outperform at Oppenheimer
07/01/20 H.C. Wainwright
Durect alcoholic hepatitis efficacy could be seen in COVID, says H.C. Wainwright
06/29/20 B. Riley FBR
Durect should be bought on weakness from Gilead termination, says B. Riley FBR
06/29/20 H.C. Wainwright
Durect thesis unchanged after Gilead termination, says H.C. Wainwright
GILD Gilead
$63.10 /

-0.29 (-0.46%)

09/20/20 Citi
Immunomedics presents at ESMO, readouts exceeded expectations, says Citi
09/18/20 RBC Capital
Gilead price target raised to $86 from $82 at RBC Capital
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/15/20 Maxim
Gilead upgraded to Buy at Maxim following Immunomedics deal
DRRX Durect
$1.69 /

-0.07 (-3.98%)

GILD Gilead
$63.10 /

-0.29 (-0.46%)

GILD Gilead
$63.10 /

-0.29 (-0.46%)

DRRX Durect
$1.69 /

-0.07 (-3.98%)

GILD Gilead
$63.10 /

-0.29 (-0.46%)

DRRX Durect
$1.69 /

-0.07 (-3.98%)

GILD Gilead
$63.10 /

-0.29 (-0.46%)

Initiation
Ingersoll-Rand initiated with a Buy at Jefferies » 06:58
09/24/20
09/24
06:58
09/24/20
06:58
IR

Ingersoll-Rand

$35.02 /

-0.07 (-0.20%)

Jefferies analyst Stephen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IR Ingersoll-Rand
$35.02 /

-0.07 (-0.20%)

IR Ingersoll-Rand
$35.02 /

-0.07 (-0.20%)

07/13/20 Morgan Stanley
Illinois Tool Works downgraded to Underweight at Morgan Stanley
06/14/20 Goldman Sachs
Ingersoll-Rand reinstated with a Neutral at Goldman Sachs
05/13/20
Fly Intel: Top five analyst downgrades
05/13/20 Baird
Ingersoll-Rand long-term thesis remain intact, says Baird
IR Ingersoll-Rand
$35.02 /

-0.07 (-0.20%)

  • 17
    Jun
IR Ingersoll-Rand
$35.02 /

-0.07 (-0.20%)

Hot Stocks
Bausch Health announces Vyzulta approval in Ukraine » 06:57
09/24/20
09/24
06:57
09/24/20
06:57
BHC

Bausch Health

$15.75 /

-0.3 (-1.87%)

Bausch Health, Bausch +…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BHC Bausch Health
$15.75 /

-0.3 (-1.87%)

BHC Bausch Health
$15.75 /

-0.3 (-1.87%)

09/17/20
Fly Intel: Top five analyst upgrades
09/17/20 BofA
Bausch Health upgraded to Neutral from Underperform at BofA
08/24/20 JPMorgan
Bausch Health shares can double into separation, says JPMorgan
08/24/20 H.C. Wainwright
Bausch Health price target lowered to $50 from $64 at H.C. Wainwright
BHC Bausch Health
$15.75 /

-0.3 (-1.87%)

BHC Bausch Health
$15.75 /

-0.3 (-1.87%)

BHC Bausch Health
$15.75 /

-0.3 (-1.87%)

Hot Stocks
Accenture sees FY21 operating cash flow $6.35B-$6.85B » 06:57
09/24/20
09/24
06:57
09/24/20
06:57
ACN

Accenture

$230.61 /

-6.11 (-2.58%)

Sees FY21 free cash flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

09/22/20 UBS
Accenture assumed with a Neutral at UBS
09/22/20 Wedbush
Accenture price target raised to $255 from $240 at Wedbush
09/22/20 Piper Sandler
Accenture price target raised to $229 from $206 at Piper Sandler
09/21/20 BMO Capital
Accenture price target raised to $255 from $215 at BMO Capital
ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

Hot Stocks
Accenture reports Q4 new bookings $14B  06:56
09/24/20
09/24
06:56
09/24/20
06:56
ACN

Accenture

$230.61 /

-6.11 (-2.58%)

 
ShowHide Related Items >><<
ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

09/22/20 UBS
Accenture assumed with a Neutral at UBS
09/22/20 Wedbush
Accenture price target raised to $255 from $240 at Wedbush
09/22/20 Piper Sandler
Accenture price target raised to $229 from $206 at Piper Sandler
09/21/20 BMO Capital
Accenture price target raised to $255 from $215 at BMO Capital
ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

ACN Accenture
$230.61 /

-6.11 (-2.58%)

Syndicate
Penn National files to sell 14M shares of common stock » 06:55
09/24/20
09/24
06:55
09/24/20
06:55
PENN

Penn National

$69.10 /

-5.24 (-7.05%)

Goldman Sachs & Co.,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PENN Penn National
$69.10 /

-5.24 (-7.05%)

PENN Penn National
$69.10 /

-5.24 (-7.05%)

06:17 Today Macquarie
Penn National downgraded to Neutral from Outperform at Macquarie
06:05 Today Macquarie
Penn National downgraded to Neutral from Outperform at Macquarie
09/22/20 Morgan Stanley
Barstool Sportsbook app 'bullish' for the sector, says Morgan Stanley
09/17/20 Stifel
Penn National price target raised to $85 from $47 at Stifel
PENN Penn National
$69.10 /

-5.24 (-7.05%)

  • 12
    May
PENN Penn National
$69.10 /

-5.24 (-7.05%)

PENN Penn National
$69.10 /

-5.24 (-7.05%)

PENN Penn National
$69.10 /

-5.24 (-7.05%)

Initiation
Tencent Music initiated with a Buy at Needham » 06:55
09/24/20
09/24
06:55
09/24/20
06:55
TME

Tencent Music

$14.73 /

-0.2 (-1.34%)

Needham analyst Vincent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TME Tencent Music
$14.73 /

-0.2 (-1.34%)

TME Tencent Music
$14.73 /

-0.2 (-1.34%)

08/14/20
Tencent Music upgraded to Outperform from Perform at Oppenheimer
08/14/20 Oppenheimer
Tencent Music upgraded to Outperform from Perform at Oppenheimer
06/30/20 UBS
Tencent Music upgraded to Buy from Neutral at UBS
06/30/20 Citi
Tencent Music initiated with a Buy at Citi
TME Tencent Music
$14.73 /

-0.2 (-1.34%)

TME Tencent Music
$14.73 /

-0.2 (-1.34%)

TME Tencent Music
$14.73 /

-0.2 (-1.34%)

Hot Stocks
CarMax plans to open 8-10 stores in FY22  06:53
09/24/20
09/24
06:53
09/24/20
06:53
KMX

CarMax

$105.98 /

+1.645 (+1.58%)

 
ShowHide Related Items >><<
KMX CarMax
$105.98 /

+1.645 (+1.58%)

KMX CarMax
$105.98 /

+1.645 (+1.58%)

09/22/20 RBC Capital
CarMax price target raised to $110 from $100 at RBC Capital
08/18/20 Wedbush
CarMax price target raised to $120 from $100 at Wedbush
08/12/20 Guggenheim
CarMax price target raised to $114 from $106 at Guggenheim
07/02/20 Oppenheimer
CarMax price target raised to $108 from $87 at Oppenheimer
KMX CarMax
$105.98 /

+1.645 (+1.58%)

KMX CarMax
$105.98 /

+1.645 (+1.58%)

KMX CarMax
$105.98 /

+1.645 (+1.58%)

KMX CarMax
$105.98 /

+1.645 (+1.58%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.